⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MRK News
Merck & Co., Inc.
Ivonescimab Shows Quality of Life Benefits in Chemotherapy-Free First-Line NSCLC: Health-Related Quality of Life Data from the HARMONi-2 Study Presented at ELCC 2026
prnewswire.com
MRK
Merck’s Enlicitide Decanoate, an Investigational Oral PCSK9 Inhibitor, Demonstrated Significantly Greater LDL-C Reductions at Eight Weeks Compared to Guideline-Recommended Oral Non-Statin Therapies When Added to Background Statins
businesswire.com
MRK
CIO 100 Awards & Conference Announces 2026 CIO 100 Honorees, Recognizing Enterprise-Scale Technology Leadership
accessnewswire.com
HPE
IBM
AVNT
AX
BAC
MSFT
BRK.A
JNJ
MRK
AMZN
GOOG
QCOM
T
VZ
MU
INTC
AMD
NVDA
CRM
ADBE
CSCO
ORCL
SAP
ACN
MS
AXP
MA
V
UNM
ALL
CB
TRV
GE
HON
MMM
DOW
DD
EL
KHC
PEP
KO
MCD
SBUX
CMG
YUM
DG
WMT
TGT
HD
LOW
COST
UPS
FDX
XPO
JBHT
CNC
CI
ELV
HCA
CVS
UNP
NSC
BNTX
MRNA
GILD
AMGN
REGN
ABBV
BMY
PFE
LLY
SNY
AZN
ELAN
MSCI
FICO
EXPD
BKNG
MAR
H
WYNN
LVS
MGM
CCL
RCL
NCLH
LULU
UA
NKE
RL
PVH
TJX
BBY
MDT
ISRG
ABT
BA
LMT
RTX
GD
CAT
DE
CNH
OSK
J
CBRE
JLL
SPG
PLD
AMT
EQIX
CCI
AVTR
BIIB
ALGN
EXPE
AEP
NEE
SO
DUK
PCG
SRE
WEC
ED
D
ETR
NI
PNW
EXC
EIX
FE
CMS
LNT
ZION
KEY
PNC
USB
WFC
JPM
GS
SCHW
SPGI
AMAT
AVGO
NXPI
ADI
TXN
MRVL
SNPS
CDNS
MCHP
ON
INFY
WDC
SE
BABA
JD
PDD
MELI
ETSY
EBAY
SHOP
PYPL
COIN
HOOD
UPST
SOFI
AFRM
PLTR
SNOW
DDOG
PANW
CRWD
ZS
FTNT
CHKP
CYBR
TENB
NTAP
STX
APP
MOVE
ACCL
AES
ALB
APLS
ASML
BKR
BROS
BWA
CHTR
EOG
EXAS
F
FCX
KMB
L
LBRDK
LUV
MAS
META
MNST
MO
MTRX
NOC
O
OC
ODFL
OTIS
OXM
PAYX
PHI
PPC
PRGO
PSX
RF
ROST
ROKU
RS
S
SEE
SIRI
TCOM
THC
THG
THS
TIGR
TMO
TMUS
TOL
TOP
TRIP
TRMB
TRN
TSLA
TTWO
TXRH
UDR
ULTA
UNFI
UNH
VRSK
VRTX
VTR
W
WHR
WMB
WST
WY
XOM
XRAY
XYL
YMM
Z
ZBH
ZBRA
ZTO
ZTS
$1.59 Billion PD-1 Resistant Head and Neck Cancer Market Analysis Report 2026: Size, Growth, and Segmentation Insights to 2030
globenewswire.com
CVM
EXEL
MRK
PFE
AZN
RPRX
Advanced Melanoma Markets and Companies 2026-2030: Cumulative Revenue to Grow by $1.87 Billion
globenewswire.com
MRK
MRNA
PFE
BMY
Carcinoid Tumor Market to Rise at 10.1% CAGR During 2026-2030: Increasing Obesity Rates Spur Growth
globenewswire.com
TMO
MRK
PFE
NVS
Cutaneous Squamous Cell Carcinoma (cSCC) Market Rises to $8.33 Billion in 2026: Roche, Merck & Co., and Sanofi Leads the Industry
globenewswire.com
MRK
SNY
BMY
NVS
CHKP
Pancreatic Adenocarcinoma Treatment Market to Grow at 13% CAGR During 2026-2030, Led by Pfizer, Roche, Merck & Co., Sanofi, Bristol-Myers Squibb, AstraZeneca, Novartis, and GlaxoSmithKline
globenewswire.com
PFE
MRK
SNY
BMY
AZN
NVS
GSK
Paraganglioma Market Trends and Investment Opportunities 2026-2030
globenewswire.com
MRK
Recurrent Head and Neck Cancer Squamous Cell Carcinoma Markets and Competition Outlook 2026-2030: Personalized Medicine Drives Revenue Growth, Reaching $4.61 Billion by 2030
globenewswire.com
AZN
ABBV
BMY
MRK